Geron Corporation (GERN) Q4 2025 Earnings Call Transcript
Source: SeekingAlpha
2026-02-25 12:17:59 ET
Geron Corporation (GERN) Q4 2025 Earnings Call February 25, 2026 8:00 AM EST
Company Participants
Dawn Schottlandt - Senior Vice President of Investor Relations & Corporate Affairs
Harout Semerjian - CEO, President & Director
Ahmed ElNawawi
Joseph Eid - Executive VP of Research & Development and Chief Medical Officer
Michelle Robertson - Executive VP, CFO, Treasurer and Principal Financial & Accounting Officer
...
Read the full article on Seeking Alpha
For further details see:
Geron Corporation (GERN) Q4 2025 Earnings Call Transcript
Geron Corporation
NASDAQ: GERN
GERN Trading
0.32% G/L:
$1.56 Last:
5,938,202 Volume:
$1.50 Open:
GERN Latest News
February 25, 2026 07:00:00 am
Geron Corporation Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Highlights
GERN Stock Data
$1,030,943,769
590,989,314
0.47%
88
N/A
Biotechnology & Life Sciences
Healthcare
US
FOSTER CITY
